| scholarly article | Q13442814 |
| P2093 | author name string | Feng Liu | |
| Yuhua Wang | |||
| Yongjun Wang | |||
| Zhenghong Xu | |||
| Dun Wang | |||
| Jingling Tang | |||
| Kelly Racette | |||
| P2860 | cites work | Relationships between the hydrophilic-lipophilic balance values of pharmaceutical excipients and their multidrug resistance modulating effect in Caco-2 cells and rat intestines | Q40645005 |
| Understanding the structure and stability of paclitaxel nanocrystals | Q41884506 | ||
| Polycationic Nanodrug Covered with Hyaluronic Acid for Treatment of P-Glycoprotein Overexpressing Cancer Cells | Q42945507 | ||
| Vitamin E TPGS P-glycoprotein inhibition mechanism: influence on conformational flexibility, intracellular ATP levels, and role of time and site of access | Q43141817 | ||
| Mechanism of pluronic effect on P-glycoprotein efflux system in blood-brain barrier: contributions of energy depletion and membrane fluidization. | Q43768000 | ||
| Optimal structure requirements for pluronic block copolymers in modifying P-glycoprotein drug efflux transporter activity in bovine brain microvessel endothelial cells | Q44285589 | ||
| Some considerations about the hydrophilic-lipophilic balance system | Q46765895 | ||
| Influence of vitamin E TPGS poly(ethylene glycol) chain length on apical efflux transporters in Caco-2 cell monolayers | Q46892593 | ||
| Intestinal transport of bis(12)-hupyridone in Caco-2 cells and its improved permeability by the surfactant Brij-35 | Q59215266 | ||
| Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity and membrane fluidity | Q79969109 | ||
| Multidrug resistance in cancer: role of ATP-dependent transporters | Q28208049 | ||
| Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: Selective energy depletion | Q28366592 | ||
| Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers. | Q30475533 | ||
| Sensitization of cells overexpressing multidrug-resistant proteins by pluronic P85. | Q34761824 | ||
| An essential relationship between ATP depletion and chemosensitizing activity of Pluronic block copolymers. | Q35204550 | ||
| Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. | Q36536479 | ||
| Paclitaxel nanocrystals for overcoming multidrug resistance in cancer | Q36623275 | ||
| Nanomicellar paclitaxel increases cytotoxicity of multidrug resistant breast cancer cells | Q37124784 | ||
| Effect of pluronic P85 on ATPase activity of drug efflux transporters | Q37179672 | ||
| Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP. | Q37378180 | ||
| Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance. | Q37844303 | ||
| Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression | Q37849716 | ||
| Optimization of a novel and improved thermosensitive liposome formulated with DPPC and a Brij surfactant using a robust in vitro system | Q39530961 | ||
| Multifunctional nanoassemblies for vincristine sulfate delivery to overcome multidrug resistance by escaping P-glycoprotein mediated efflux | Q39547418 | ||
| Overcoming multidrug resistance of breast cancer cells by the micellar doxorubicin nanoparticles of mPEG-PCL-graft-cellulose | Q39568845 | ||
| Paclitaxel-loaded poly(n-butylcyanoacrylate) nanoparticle delivery system to overcome multidrug resistance in ovarian cancer | Q39616068 | ||
| Poly(L-lactide)-vitamin E TPGS nanoparticles enhanced the cytotoxicity of doxorubicin in drug-resistant MCF-7 breast cancer cells | Q39665776 | ||
| Effect of excipients on breast cancer resistance protein substrate uptake activity | Q40075189 | ||
| Effect of intratumoral injection of carboplatin combined with pluronic P85 or L61 on experimental colorectal carcinoma in rats. | Q40111948 | ||
| Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux. | Q40277654 | ||
| P433 | issue | 2 | |
| P921 | main subject | multiple drug resistance | Q643839 |
| P304 | page(s) | 424-430 | |
| P577 | publication date | 2013-01-24 | |
| P1433 | published in | Biomacromolecules | Q1768006 |
| P1476 | title | Key structure of brij for overcoming multidrug resistance in cancer | |
| P478 | volume | 14 |
| Q40713954 | Design and evaluation of proniosomes as a carrier for ocular delivery of lomefloxacin HCl. |
| Q55518745 | Dual-functional Brij-S20-modified nanocrystal formulation enhances the intestinal transport and oral bioavailability of berberine. |
| Q51369267 | Effects of 2 Polyoxyethylene Alkyl Ethers on the Function of Intestinal P-glycoprotein and Their Inhibitory Mechanisms. |
| Q87445546 | Effects of Polyoxyethylene Alkyl Ethers on the Intestinal Transport and Absorption of Rhodamine 123: A P-glycoprotein Substrate by In Vitro and In Vivo Studies |
| Q57348137 | Hydrophilic–oleophobic coatings on cellulosic materials by plasma assisted polymerization in liquid phase and fluorosurfactant complexation |
| Q39514853 | Nonionic surfactant structure on the drug release, formulation and physical properties of ethylcellulose microspheres |
| Q58322939 | Simulations Study of Single-Component and Mixed n-Alkyl-PEG Micelles |
| Q37594151 | Solid lipid nanoparticles with TPGS and Brij 78: A co-delivery vehicle of curcumin and piperine for reversing P-glycoprotein-mediated multidrug resistance in vitro |
| Q39000197 | The ruthenium complexes cis-(dichloro)tetramineruthenium(III) chloride and cis-tetraammine(oxalato)ruthenium(III) dithionate overcome resistance inducing apoptosis on human lung carcinoma cells (A549). |
| Q89910214 | Triphenylphosphonium-modified mitochondria-targeted paclitaxel nanocrystals for overcoming multidrug resistance |
| Q34028996 | Unclassified renal cell carcinoma: a clinicopathological, comparative genomic hybridization, and whole-genome exon sequencing study |
| Q38808499 | Vitamin E derivative-based multifunctional nanoemulsions for overcoming multidrug resistance in cancer |
| Q35934993 | pH-Responsive therapeutic solid lipid nanoparticles for reducing P-glycoprotein-mediated drug efflux of multidrug resistant cancer cells |
Search more.